Lv1
40 积分 2026-02-05 加入
Safety, tolerability, pharmacokinetics and efficacy of HB0017, a humanized monoclonal antibody that targets interleukin-17A, in healthy participants and patients with moderate-to-severe plaque psoriasis
5小时前
求助中
HLA Class II Alleles DRB1*11:01 and DQB1*03:01 Unmask Immunogenetic Susceptibility to Anti-Nivolumab Antibodies in Combination with Ipilimumab
16天前
已关闭
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
29天前
已完结
FGF21 reverses MASH through coordinated actions on the CNS and liver
1个月前
已完结
Enhanced bioactivity and stability of a long-acting FGF21: A novel variant for the treatment of NASH
1个月前
已完结
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management
2个月前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
2个月前
已完结
Evaluating the Immunogenicity Risk of Protein Therapeutics by Augmenting T Cell Epitope Prediction with Clinical Factors
2个月前
已完结
Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial
2个月前
已完结
Comparative efficacy of pharmacologic therapies for MASLD in improving fibrosis: systematic review and network meta-analysis
2个月前
已关闭
皖公网安备34019202002308
